ArticleJournal of controlled release : official journal of the Controlled Release Society2019

Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers.

O B Garbuzenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.